Share
Share
Arbor Research Collaborative for Health (Arbor Research), a leading provider of innovative solutions in healthcare research, is pleased to announce its participation in the upcoming World Congress of Nephrology (WCN) 2024, scheduled to take place from April 13th to 16th, 2024.
The WCN 2024 conference, organized by the International Society of Nephrology (ISN), is a prestigious event that brings together professionals and experts from around the globe to discuss the latest advancements, research findings, and trends in nephrology and related fields.
The presentations will feature Arbor Research’s distinguished speakers, Dr. Roberto Silva Pecoits-Filho, MD, PhD, FACP, FASN and Dr. Angelo Karaboyas, PhD, renowned for their contributions to nephrology research and healthcare outcomes. Attendees can expect to gain valuable insights into the latest developments in renal research, treatment strategies, and advancements in kidney disease management. Q and A session will close each session.
Sunday April 14, 2024
3:00-4:00 PM, Hall A
Should Potassium Be Restricted or Not in CKD? Roberto Silva Pecoits-Filho, MD, PhD, FACP, FASN
Session: A Balancing Act: Your Kidneys and Electrolytes
Chairperson: Yee Moon Angela WANG and Thiago Reis
4:30-5:30 PM, Hall C4
Trial Simulation Using Observational Data. Angelo Karaboyas, PhD, 4:45-5:00 PM
Session: New Developments in CKD Epidemiology Research
Chairperson: Roberto Silva Pecoits-Filho and Maarten Taal
Poster Presentations
Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS):
Substantial Sex Differences in Peritoneal Dialysis Outcomes: Results from PDOPPS. Rehab Albakr et al.
5:45-6:45; Exhibition Hall and Main Foyer
Session: Peritoneal Dialysis 2
Chronic Kidney Disease Dialysis Outcomes and Practice Patterns Study (CKDOPPS):
International Differences in Patient Care During the Transition from Advanced CKD to Kidney Replacement Therapies. Murilo Guedes et al.
5:45-6:45; Exhibition Hall and Main Foyer
Session: Epidemiology, Outcomes and Health Services Research in Dialysis 2
Monday April 15, 2024
4:30-5:30 PM, Hall C3
International Trends and Variations in Hemodiafiltration Utilization and Practices. Angelo Karaboyas, PhD; 5:00-5:15 PM
Session: Recent Trends in Global Nephrology – Care of Advanced CKD and Dialysis Patients: ISN-DOPPS Joint Session
Chairperson: Jonathan Chavez Iniguez and Guang-YanCai
Arbor Research invites all attendees, delegates, and media representatives to join these informative sessions and engage with our experts to explore cutting-edge topics shaping the future of nephrology.
For more information about Arbor Research’s participation in WCN 2024 or to schedule interviews with our speakers, please contact us:
Communications@arborresearch.org
December 5, 2024 — Arbor Research Collaborative for Health is proud to announce an innovative collaboration with the Nephrology Associates of Northern Illinois and Indiana (NANI), the largest private nephrology practice in the United States. This partnership marks a significant milestone in advancing chronic kidney disease (CKD) research and management by leveraging NANI’s extensive patient-level […]
Arbor Research Collaborative for Health is excited to announce a partnership with CSL Vifor to launch a multinational registry designed to capture real-world outcomes of difelikefalin (Kapruvia®), a newly-approved treatment for chronic kidney disease-associated pruritus (CKD-aP) in hemodialysis (HD) patients. Known as PARADIGM (PAn european Registry Addressing pruritus in DIalysis with a focus on Goal […]
The Health Resources and Services Administration (HRSA) has selected Arbor Research Collaborative for Health (Arbor Research) as one of 14 organizations who will lead the modernization of the Organ Procurement and Transplantation Network (OPTN). Arbor Research received one of the five initial efforts, focusing on improving patient safety and policy compliance systems and processes overseen […]
Arbor Research Collaborative for Health (Arbor Research) is proud to announce that its wholly-owned, small-business subsidiary, Arbor Research LLC, received its first competitive prime contract award. The award expands the organization’s 25-year history doing mission-impactful work in chronic disease and beyond. Arbor Research was awarded the National Cancer Institute (NCI) Center for Global Health (CGH) […]